A detailed history of Commonwealth Equity Services, LLC transactions in Immunome Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 20,118 shares of IMNM stock, worth $344,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,118
Previous 20,917 3.82%
Holding current value
$344,822
Previous $195,000 21.03%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

SELL
$8.4 - $11.59 $6,711 - $9,260
-799 Reduced 3.82%
20,118 $236,000
Q2 2025

Aug 06, 2025

BUY
$5.56 - $9.79 $2,068 - $3,641
372 Added 1.81%
20,917 $195,000
Q1 2025

May 09, 2025

BUY
$6.73 - $11.83 $10,283 - $18,076
1,528 Added 8.03%
20,545 $138,000
Q4 2024

Feb 10, 2025

BUY
$9.11 - $14.53 $173,244 - $276,317
19,017 New
19,017 $202,000

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $208M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.